2026: NextGen BioMed

March 12, 2026

We'll be exhibiting at NextGen BioMed in London - March 24 and 25! Stop by our booth and be sure to check out Nat Goldberg's talk on Mar 25 at 10:15am on the "Peptide Therapeutics & Development" track.

Share:

Previous Title

Next Title

November 6, 2020

Research: Scalable continuous evolution

Scalable continuous evolution for the generation of diverse enzyme variants encompassing promiscuous activities

Research: Asymmetric Alkylation of Ketones Catalyzed by Engineered TrpB

We show that ketone-derived enolates can serve as nucleophiles in the TrpB reaction to achieve the asymmetric alkylation of ketones

Featured in CHEManager International

Our founders were interviewed in this strategic news publication for the chemical and pharmaceutical industries.

September 10, 2023

Aralez In the Community

Our founder & team are featured in Made in San Leandro: Celebrating Women in Manufacturing series

IOPC

Our founder presents "Expanding the Universe of Noncanonical Amino Acids with Biocatalysis"

September 30, 2025

16th Australian Peptide Conference

Our founder discusses "Novel Amino Acids for Peptide Therapeutics via Green Biocatalysis"

August 10, 2025

Boulder Peptide Symposium

Come meet our founder & team as we discuss the critical role that ncAAs play in peptide drug development

The Importance of Noncanonical Amino Acids in Peptide Therapeutics

Check out our latest paper discussing how noncanonical amino acids are used in discovery, manufacturing, as well as the challenges in the industry

October 29, 2024

Series A Financing Round

Aralez Bio announces Series A Financing Round

Research: Tryptophan Synthase: Biocatalyst Extraordinaire

This review examines the long and storied career of TrpS from the perspective of its application in ncAA synthesis and biocatalytic cascades.